nine hypertensive patients with mild to moderate renal dysfunction were entered into a protocol to assess the blood pressure , humoral and renal effects of the angiotensin converting enzyme inhibitor , benazepril ( cgs14824a , 2 to 20 mg twice daily ) in patients with hypertension and moderate renal insufficiency ( mean creatinine clearance 56 ml/min/1.73 m2 ) .
C0022646
renal
C0035078
renal insufficiency